CXCL10 is an important pro-inflammatory cytokine and has been reported to mediate the mobilization of tumor-inhibitory CXCR3+ T cells, as well as natural killer cells, into solid cancers (Tokunaga et al., 2018). This evidence concerns the gene CXCR3 and neoplasm.